1-20 of 66
Authors: J.R. Ingram
Sort by
Journal Article
Checking for update…living systematic reviews and clinical practice guidelines in the BJD
Get access
Z.Z.N. Yiu and others
British Journal of Dermatology, Volume 186, Issue 5, 1 May 2022, Pages 761–762, https://doi.org/10.1111/bjd.20896
Published: 01 May 2022
Journal Article
Anakinra for palmoplantar pustulosis: results from a randomized, double‐blind, multicentre, two‐staged, adaptive placebo‐controlled trial (APRICOT)
Get access
S. Cro and others
British Journal of Dermatology, Volume 186, Issue 2, 1 February 2022, Pages 245–256, https://doi.org/10.1111/bjd.20653
Published: 01 February 2022
Journal Article
Thematic synthesis of the experiences of people with hidradenitis suppurativa: a systematic review
L. Howells and others
British Journal of Dermatology, Volume 185, Issue 5, 1 November 2021, Pages 921–934, https://doi.org/10.1111/bjd.20523
Published: 01 November 2021
Journal Article
Dermatology is finally talking about race
Get access
J. Guckian and others
British Journal of Dermatology, Volume 185, Issue 5, 1 November 2021, Pages 875–876, https://doi.org/10.1111/bjd.20599
Published: 01 November 2021
Journal Article
Widening the tightrope: new abstract guidelines for BJD authors
Get access
A.M. Drucker and J.R. Ingram
British Journal of Dermatology, Volume 185, Issue 4, 1 October 2021, Pages 687–688, https://doi.org/10.1111/bjd.20498
Published: 01 October 2021
Journal Article
The essential role of dermatology publications in enhancing professional diversity, equity and inclusion
Get access
S. Burgin and others
British Journal of Dermatology, Volume 185, Issue 3, 1 September 2021, Pages 473–474, https://doi.org/10.1111/bjd.20473
Published: 01 September 2021
Journal Article
Core outcome set implementation supported by the BJD
Get access
E.C. Veysey and others
British Journal of Dermatology, Volume 184, Issue 6, 1 June 2021, Pages 987–989, https://doi.org/10.1111/bjd.20050
Published: 01 June 2021
Journal Article
An economic evaluation of the randomized controlled trial of topical corticosteroid and home‐based narrowband ultraviolet B for active and limited vitiligo (the HI‐Light Vitiligo Trial)
T.H. Sach and others
British Journal of Dermatology, Volume 184, Issue 5, 1 May 2021, Pages 840–848, https://doi.org/10.1111/bjd.19554
Published: 01 May 2021
Journal Article
Randomized controlled trial of topical corticosteroid and home‐based narrowband ultraviolet B for active and limited vitiligo: results of the HI‐Light Vitiligo Trial
K.S. Thomas and others
British Journal of Dermatology, Volume 184, Issue 5, 1 May 2021, Pages 828–839, https://doi.org/10.1111/bjd.19592
Published: 01 May 2021
Includes: Multimedia
Journal Article
Validation of global item for assessing impact on quality of life of patients with hidradenitis suppurativa
Get access
J.S. Kirby and others
British Journal of Dermatology, Volume 184, Issue 4, 1 April 2021, Pages 681–687, https://doi.org/10.1111/bjd.19344
Published: 01 April 2021
Journal Article
The pharmacology of itch
Get access
J.R. Ingram and A. Ahluwalia
British Journal of Dermatology, Volume 184, Issue 1, 1 January 2021, Pages e1–e2, https://doi.org/10.1111/bjd.18525
Published: 01 January 2021
Journal Article
Effectiveness of a stop smoking service in reducing cigarette smoking in patients referred from a National Health Service dermatology centre
Get access
L.F. Soriano and others
British Journal of Dermatology, Volume 183, Issue 6, 1 December 2020, Pages 1119–1121, https://doi.org/10.1111/bjd.19378
Published: 01 December 2020
Journal Article
Systematic review of the efficacies and adverse effects of treatments for pityriasis lichenoides
Get access
F. Jung and others
British Journal of Dermatology, Volume 183, Issue 6, 1 December 2020, Pages 1026–1032, https://doi.org/10.1111/bjd.18977
Published: 01 December 2020
Journal Article
The prevalence of hidradenitis suppurativa is shown by the Secure Anonymised Information Linkage (SAIL) Databank to be one per cent of the population of Wales
J.R. Ingram and others
British Journal of Dermatology, Volume 183, Issue 5, 1 November 2020, Pages 950–952, https://doi.org/10.1111/bjd.19210
Published: 01 November 2020
Journal Article
What has changed in the UK management of hidradenitis suppurativa from 2014 to 2019?
Get access
S.B. Hasan and J.R. Ingram
British Journal of Dermatology, Volume 183, Issue 5, 1 November 2020, Pages 973–975, https://doi.org/10.1111/bjd.19302
Published: 01 November 2020
Journal Article
Global Hidradenitis Suppurativa COVID‐19 Registry: a registry to inform data‐driven management practices
H.B. Naik and others
British Journal of Dermatology, Volume 183, Issue 4, 1 October 2020, Pages 780–781, https://doi.org/10.1111/bjd.19345
Published: 01 October 2020
Journal Article
The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials
Get access
J.S. Kirby and others
British Journal of Dermatology, Volume 183, Issue 2, 1 August 2020, Pages 340–348, https://doi.org/10.1111/bjd.18692
Published: 01 August 2020
Journal Article
Publication of national dermatology guidelines as a Research Letter in the BJD: can less ever be enough?
Get access
E.J. van Zuuren and others
British Journal of Dermatology, Volume 182, Issue 6, 1 June 2020, Pages 1319–1320, https://doi.org/10.1111/bjd.18952
Published: 01 June 2020
Journal Article
Hidradenitis Suppurativa Area and Severity Index (HASI): a pilot study to develop a novel instrument to measure the physical signs of hidradenitis suppurativa
Get access
N. Goldfarb and others
British Journal of Dermatology, Volume 182, Issue 1, 1 January 2020, Pages 240–242, https://doi.org/10.1111/bjd.18335
Published: 01 January 2020
Journal Article
British Association of Dermatologists centenary year: standing on the shoulders of giants
Get access
J.R. Ingram and D. J. Gawkrodger
British Journal of Dermatology, Volume 182, Issue 1, 1 January 2020, Pages 1–2, https://doi.org/10.1111/bjd.18605
Published: 01 January 2020
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals